Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Comcast
CMCSA
|
+$1.02B |
| 2 |
Travelers Companies
TRV
|
+$983M |
| 3 |
TC Energy
TRP
|
+$886M |
| 4 |
Xcel Energy
XEL
|
+$761M |
| 5 |
General Mills
GIS
|
+$716M |
Top Sells
| 1 |
Enbridge
ENB
|
+$1.75B |
| 2 |
Boeing
BA
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.07B |
| 5 |
Amazon
AMZN
|
+$797M |
Sector Composition
| 1 | Technology | 21.35% |
| 2 | Healthcare | 17.96% |
| 3 | Communication Services | 14.6% |
| 4 | Financials | 13.2% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Arcosa
ACA
$4.66B
| $55.8M | 0.02% |
1,321,800
+308,800
| +30% | +$13M |
|
|
KRTX
302
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $52.9M | 0.02% |
474,600
| – | – |
|
303
Carnival Corp
CCL
$42.4B
| $51.2M | 0.02% |
3,119,809
-133
| -0% | -$2.18K |
|
304
Carrier Global
CARR
$52.1B
| $50M | 0.02% |
+2,248,977
| New | +$50M |
|
305
Kratos Defense & Security Solutions
KTOS
$11.9B
| $48.7M | 0.02% |
3,116,442
+758,742
| +32% | +$11.9M |
|
|
HUYA
306
Huya Inc
HUYA
$780M
| $48.1M | 0.02% |
2,576,716
-682,379
| -21% | -$12.7M |
|
307
Nexa Resources
NEXA
$670M
| $45.7M | 0.02% |
6,889,813
+55,528
| +0.8% | +$369K |
|
308
FTI Consulting
FCN
$5.27B
| $45.2M | 0.01% |
394,900
+8,700
| +2% | +$997K |
|
309
Citigroup
C
$184B
| $44.9M | 0.01% |
+878,665
| New | +$44.9M |
|
310
Franco-Nevada
FNV
$39.3B
| $44.8M | 0.01% |
321,091
-17
| -0% | -$2.37K |
|
311
Vir Biotechnology
VIR
$665M
| $44.8M | 0.01% |
1,094,305
| – | – |
|
312
Galapagos
GLPG
$2.1B
| $43.3M | 0.01% |
+220,321
| New | +$43.3M |
|
|
EV
313
DELISTED
Eaton Vance Corp.
EV
| $42.1M | 0.01% |
1,089,955
+1,010,003
| +1,263% | +$39M |
|
314
BCE
BCE
$22.1B
| $41.9M | 0.01% |
1,001,925
| – | – |
|
315
Saia
SAIA
$8.51B
| $41.7M | 0.01% |
375,200
| – | – |
|
316
Cardinal Health
CAH
$35.9B
| $41.6M | 0.01% |
797,019
| – | – |
|
317
Alibaba
BABA
$377B
| $41.2M | 0.01% |
190,975
-930,348
| -83% | -$201M |
|
318
CRISPR Therapeutics
CRSP
$5.26B
| $40.6M | 0.01% |
553,115
| – | – |
|
319
Mattel
MAT
$5.61B
| $38.1M | 0.01% |
3,941,175
| – | – |
|
320
Intuitive Surgical
ISRG
$156B
| $38M | 0.01% |
200,157
| – | – |
|
321
Novanta
NOVT
$4.09B
| $35.8M | 0.01% |
335,300
| – | – |
|
322
Health Catalyst
HCAT
$212M
| $35.7M | 0.01% |
1,223,800
+531,100
| +77% | +$15.5M |
|
|
LOMA
323
Loma Negra
LOMA
$880M
| $35.7M | 0.01% |
8,374,187
+612,729
| +8% | +$2.61M |
|
324
Baker Hughes
BKR
$45.6B
| $33.8M | 0.01% |
2,198,035
-246,869
| -10% | -$3.8M |
|
325
Yeti Holdings
YETI
$2.82B
| $33.4M | 0.01% |
780,700
| – | – |
|